Large-scale testing (Phase 3)WithdrawnNCT01245816
What this trial is testing
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
Who this might be right for
Familial Adenomatous Polyposis
Cancer Prevention Pharmaceuticals, Inc.